Benefit/Risk Assessment foR non-PRescRiPtion DRug cAnDiDAtes
نویسنده
چکیده
regulatory decision making in the assessment of drugs proposed as candidates for nonprescription status. They proposed, inter alia, a ‘value tree’ approach to allow the identification of drug specific attributes within common domains which apply to the benefits and risks of all nonprescription drugs. In doing so they created the components of a potential common language for the evaluation of medicines being considered for non-prescription use.
منابع مشابه
Risk Assessment of Drug Management Process in Women Surgery Department of Qaem Educational Hospital (QEH) Using HFMEA Method (2013)
Evaluation and improvement of drug management process is essential for patient safety. The present study was performed whit the aim of assessing risk of drug management process in Women Surgery Department of QEH using HFMEA method in 2013. A mixed method was used to analys failure modes and their effects with HFMEA. To classify failure modes; nursing errors in clinical management model, for cla...
متن کاملRisk Assessment of Drug Management Process in Women Surgery Department of Qaem Educational Hospital (QEH) Using HFMEA Method (2013)
Evaluation and improvement of drug management process is essential for patient safety. The present study was performed whit the aim of assessing risk of drug management process in Women Surgery Department of QEH using HFMEA method in 2013. A mixed method was used to analys failure modes and their effects with HFMEA. To classify failure modes; nursing errors in clinical management model, for cla...
متن کاملStill the Great Debate – “Fair Balance” in Direct-to-Consumer Prescription Drug Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
The above titled paper examined the Food and Drug Administration’s (FDA’s) warning letters and notice of violations (NOV) over a 10-year period. Findings from this content analysis reinforced what has been the primary issue for prescription direct-to-consumer advertising (DTCA) since its beginning, the fair balance of risk and benefit information. As opposed to another analysis in 2026 about th...
متن کاملTrouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters
Background For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns regarding online promotion of prescription drugs advertised directly to consumers, this study examines notices of violations (NOVs) and warning letters issued by the FDA to pharmaceutical manufacturers. Methods The FDA’s warning letters and NOVs, which were issued to pharmaceutical companies over a...
متن کاملThe Effect of Modern Educational Strategies in Reducing Intravenous Drug Administration Error: A Non-Randomized Clinical Trial
Introduction: Among medication errors, intravenous medication administration errors are especially important. The lack of medication information can be one of the causes of medication errors. Using electronic education may facilitate quick access to the update resources. The objective of this study is the evaluation of an appropriate educational strategy to reduce intravenous drug administratio...
متن کامل